Generally, locally manufactured generics dominate these markets.Teva's growth increasingly is going to be in these emerging markets, including Latin America, Russia and Eastern Europe, whose economies are growing twice as fast as the U.S. and three times as fast as Western Europe, said Hambrecht's Forman, noting that Teva has a market presence in 80 countries.Forman said he was bearish on gene